Windlas Biotech Ltd.
BSE: 543329 | Sector: Health care |
NSE: WINDLAS | ISIN Code: INE0H5O01029 |
BSE 15:01 | 20 Mar | 241.40 |
1.85 (0.77%) |
OPEN
240.00 |
HIGH
241.40 |
LOW
237.85 |
NSE 14:49 | 20 Mar | 240.55 |
0.60 (0.25%) |
OPEN
242.25 |
HIGH
243.50 |
LOW
237.85 |
OPEN | 240.00 |
PREVIOUS CLOSE | 239.55 |
VOLUME | 306 |
52-Week high | 280.00 |
52-Week low | 203.15 |
P/E | 11.04 |
Mkt Cap.(Rs cr) | 513 |
Buy Price | 240.40 |
Buy Qty | 5.00 |
Sell Price | 241.85 |
Sell Qty | 5.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Windlas Biotech Ltd. (WINDLAS) - Financial Overview
Particulars (![]() |
2022 | 2021 | 2020 |
Net Sales | 465.93 | 427.60 | 328.85 |
Operating Profit | 59.61 | 25.44 | 41.64 |
Other Income | 6.71 | 3.09 | 0.96 |
Interest | 1.42 | 1.29 | 2.37 |
Depreciation | 12.15 | 12.97 | 8.69 |
Profit Before Tax | 46.04 | 11.18 | 30.58 |
Tax | 7.48 | 6.17 | 8.12 |
Profit After Tax | 38.56 | 5.01 | 22.46 |
Share Capital | 10.90 | 6.41 | 6.41 |
Reserves | 384.23 | 192.58 | 210.07 |
Net Worth | 395.13 | 198.99 | 216.48 |
Loans | 8.44 | 33.91 | 28.63 |
Gross Block | 163.87 | 157.00 | 140.72 |
Investments | 64.86 | 23.18 | 120.98 |
Cash | 113.81 | 30.96 | 18.38 |
Debtors | 110.77 | 79.41 | 64.56 |
Net Working Capital | 239.52 | 113.75 | 55.70 |
Operating Profit Margin (%) | 12.79 | 5.95 | 12.66 |
Net Profit Margin (%) | 8.28 | 1.17 | 6.83 |
Earning Per Share (Rs) | 17.69 | 7.81 | 35.03 |
Dividend (%) | 70.00 | 0.00 | 0.00 |
Dividend Payout | 0.00 | 0.00 | 0.00 |
Quick Links for Windlas Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices